Phase I/II study of docetaxel combined with resminostat, an oral hydroxamic acid HDAC inhibitor, for advanced non-small cell lung cancer in patients previously treated with platinum-based chemotherapy

Tambo, Yuichi; Hosomi, Yukio; Sakai, Hiroshi; Nogami, Naoyuki; Atagi, Shinji; Sasaki, Yasutsuna; Kato, Terufumi; Takahashi, Toshiaki; Seto, Takashi; Maemondo, Makoto; Nokihara, Hiroshi; Koyama, Ryo; Nakagawa, Kazuhiko; Kawaguchi, Tomoya; Okamura, Yuta; Nakamura, Osamu; Nishio, Makoto; Tamura, Tomohide

doi:https://doi.org/10.1007/s10637-017-0435-2

WEKO3

lat lon distance

[[sub_check.contents]]

[[sub_radio.contents]]

Field does not validate

[[sub_attr.contents]]　

インデックスツリー

アイテム

Phase I/II study of docetaxel combined with resminostat, an oral hydroxamic acid HDAC inhibitor, for advanced non-small cell lung cancer in patients previously treated with platinum-based chemotherapy

https://iwatemed.repo.nii.ac.jp/records/2000734

Item type

学術雑誌論文 / Journal Article(1)

公開日

2024-11-06

タイトル

Phase I/II study of docetaxel combined with resminostat, an oral hydroxamic acid HDAC inhibitor, for advanced non-small cell lung cancer in patients previously treated with platinum-based chemotherapy

言語

eng

資源タイプ

資源タイプ識別子

http://purl.org/coar/resource_type/c_6501

資源タイプ

journal article

アクセス権

metadata only access

アクセス権URI

http://purl.org/coar/access_right/c_14cb

著者

Tambo, Yuichi
Hosomi, Yukio
Sakai, Hiroshi
Nogami, Naoyuki
Atagi, Shinji
Sasaki, Yasutsuna
Kato, Terufumi
Takahashi, Toshiaki
Seto, Takashi
Maemondo, Makoto
Nokihara, Hiroshi
Koyama, Ryo
Nakagawa, Kazuhiko
Kawaguchi, Tomoya
Okamura, Yuta
Nakamura, Osamu
Nishio, Makoto
Tamura, Tomohide

bibliographic_information

en : Investigational new drugs

巻 35, 号 2, p. 217-226, 発行日 2017-04

出版者

Springer

言語

item_10001_source_id_9

収録物識別子タイプ

PISSN

収録物識別子

0167-6997

Versions

Ver.1

2024-11-12 02:31:53.674787

Show All versions

Cite as

エクスポート

OAI-PMH

JPCOAR 2.0
JPCOAR 1.0
DublinCore
DDI

Other Formats

JSON
BIBTEX

インデックスリンク

インデックスツリー

アイテム

Phase I/II study of docetaxel combined with resminostat, an oral hydroxamic acid HDAC inhibitor, for advanced non-small cell lung cancer in patients previously treated with platinum-based chemotherapy

× Tambo, Yuichi

× Hosomi, Yukio

× Sakai, Hiroshi

× Nogami, Naoyuki

× Atagi, Shinji

× Sasaki, Yasutsuna

× Kato, Terufumi

× Takahashi, Toshiaki

× Seto, Takashi

× Maemondo, Makoto

× Nokihara, Hiroshi

× Koyama, Ryo

× Nakagawa, Kazuhiko

× Kawaguchi, Tomoya

× Okamura, Yuta

× Nakamura, Osamu

× Nishio, Makoto

× Tamura, Tomohide

Versions

Share

Cite as

エクスポート